1.
J Wound Care
; 17(9): 380-2, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18833895
RESUMO
This rare ulcer was treated with a human recombinant epidermal growth factor-based formulation and antihypertensive drugs. Full granulation was achieved in 49 days and complete wound closure in 79 days. No adverse events were reported.